239 related articles for article (PubMed ID: 2554768)
1. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?
Sacks SL; Wanklin RJ; Reece DE; Hicks KA; Tyler KL; Coen DM
Ann Intern Med; 1989 Dec; 111(11):893-9. PubMed ID: 2554768
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
3. [Resistance of herpes simplex viruses to antiviral drugs].
Scieux C; Bianchi A
Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
[TBL] [Abstract][Full Text] [Related]
4. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
Field HJ; Neden J
Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of a herpes simplex virus clinical isolate exhibiting resistance to acyclovir and foscarnet.
Pelosi E; Hicks KA; Sacks SL; Coen DM
Adv Exp Med Biol; 1992; 312():151-8. PubMed ID: 1325102
[TBL] [Abstract][Full Text] [Related]
6. Significance of resistance of herpes simplex virus to acyclovir.
Crumpacker CS
J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):190-5. PubMed ID: 2828441
[TBL] [Abstract][Full Text] [Related]
7. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
Larder BA; Darby G
Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
[TBL] [Abstract][Full Text] [Related]
8. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
Chibo D; Mijch A; Doherty R; Birch C
J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.
Collins P; Ellis MN
J Med Virol; 1993; Suppl 1():58-66. PubMed ID: 8245894
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir.
Collins P; Larder BA; Oliver NM; Kemp S; Smith IW; Darby G
J Gen Virol; 1989 Feb; 70 ( Pt 2)():375-82. PubMed ID: 2543743
[TBL] [Abstract][Full Text] [Related]
11. Acyclovir resistance in a patient with chronic mucocutaneous herpes simplex infection.
Westheim AI; Tenser RB; Marks JG
J Am Acad Dermatol; 1987 Nov; 17(5 Pt 2):875-80. PubMed ID: 2824577
[TBL] [Abstract][Full Text] [Related]
12. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
[TBL] [Abstract][Full Text] [Related]
13. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum.
Levin MJ; Weinberg A; Leary JJ; Sarisky RT
Pediatr Infect Dis J; 2001 Nov; 20(11):1094-7. PubMed ID: 11734722
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.
Safrin S; Phan L
Antimicrob Agents Chemother; 1993 Oct; 37(10):2241-3. PubMed ID: 8257152
[TBL] [Abstract][Full Text] [Related]
16. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
[TBL] [Abstract][Full Text] [Related]
17. Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance.
Schmidt S; Bohn-Wippert K; Schlattmann P; Zell R; Sauerbrei A
Antimicrob Agents Chemother; 2015 Aug; 59(8):4938-45. PubMed ID: 26055375
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
Sall RK; Kauffman CL; Levy CS
Arch Dermatol; 1989 Nov; 125(11):1548-50. PubMed ID: 2554819
[TBL] [Abstract][Full Text] [Related]
19. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS.
Gateley A; Gander RM; Johnson PC; Kit S; Otsuka H; Kohl S
J Infect Dis; 1990 Apr; 161(4):711-5. PubMed ID: 2156946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
